Neue Entwicklungen der Epileptogenese und therapeutische Perspektiven

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Der Nervenarzt

• Publication date

  2011-07-27

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1007/s00115-011-3260-4
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Idiopathische generalisierte Epilepsien

  2011cited by this paper
• Randomized, double-blind, placebo-controlled trial of ezogabine (retigabine) in partial epilepsy

  2011cited by this paper
• Epigenetische Pathomechanismen der Epileptogenese

  2011cited by this paper
• The role of inflammation in epilepsy

  2011cited by this paper
• Revised terminology and concepts for organization of seizures and epilepsies: Report of the ILAE Commission on Classification and Terminology, 2005–2009

  2010cited by this paper
• Glucose transporter-1 deficiency syndrome: the expanding clinical and genetic spectrum of a treatable disorder.

  2010cited by this paper
• Efficacy and safety of adjunctive ezogabine (retigabine) in refractory partial epilepsy

  2010cited by this paper
• Recurrent microdeletions at 15q11.2 and 16p13.11 predispose to idiopathic generalized epilepsies.

  2010cited by this paper
• Epigenetic choreographers of neurogenesis in the adult mammalian brain

  2010cited by this paper
• Mechanisms of human inherited epilepsies.

  2009cited by this paper
• Activity-dependent control of neuronal output by local and global dendritic spike attenuation.

  2009cited by this paper
• Dose‐dependent memory effects and cerebral volume changes after in utero exposure to valproate in the rat

  2009cited by this paper
• Increased Reelin Promoter Methylation Is Associated With Granule Cell Dispersion in Human Temporal Lobe Epilepsy

  2009cited by this paper
• Early‐onset absence epilepsy caused by mutations in the glucose transporter GLUT1

  2009cited by this paper
• 15q13.3 microdeletions increase risk of idiopathic generalized epilepsy

  2009cited by this paper
• Epigenetic mechanisms in neurological diseases: genes, syndromes, and therapies.

  2009cited by this paper
• Management issues for women with epilepsy—Focus on pregnancy (an evidence‐based review): I. Obstetrical complications and change in seizure frequency

  2009cited by this paper
• Plasticity of intrinsic neuronal properties in CNS disorders

  2008cited by this paper
• GLUT1 mutations are a cause of paroxysmal exertion-induced dyskinesias and induce hemolytic anemia by a cation leak.

  2008cited by this paper
• Histone deacetylase inhibitors: possible implications for neurodegenerative disorders

  2008cited by this paper
• Pyramidal neurons: dendritic structure and synaptic integration

  2008cited by this paper
• Nervous system KV7 disorders: breakdown of a subthreshold brake

  2008cited by this paper
• Imaging cellular network dynamics in three dimensions using fast 3D laser scanning

  2007cited by this paper
• Circuit-breakers: optical technologies for probing neural signals and systems

  2007cited by this paper
• Phenotypic plasticity and the epigenetics of human disease

  2007cited by this paper
• Rescue of the reeler phenotype in the dentate gyrus by wild‐type coculture is mediated by lipoprotein receptors for reelin and disabled 1

  2006cited by this paper
• Prospects: Histone deacetylase inhibitors

  2005cited by this paper
• Ion channel defects in idiopathic epilepsies.

  2005cited by this paper
• Valproic acid: an old drug newly discovered as inhibitor of histone deacetylases.

  2004cited by this paper
• Genetic mechanisms that underlie epilepsy

  2004cited by this paper
• Mutations in High-Voltage-Activated Calcium Channel Genes Stimulate Low-Voltage-Activated Currents in Mouse Thalamic Relay Neurons

  2002cited by this paper
• Role for Reelin in the Development of Granule Cell Dispersion in Temporal Lobe Epilepsy

  2002cited by this paper
• De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy.

  2001cited by this paper
• The novel anticonvulsant retigabine activates M-currents in Chinese hamster ovary-cells tranfected with human KCNQ2/3 subunits.

  2000cited by this paper
• Live cell imaging by multifocal multiphoton microscopy.

  2000cited by this paper
• Acetylation of Histones and Transcription-Related Factors

  2000cited by this paper
• Neuronal KCNQ potassium channels:physislogy and role in disease

  2000cited by this paper
• Emerging insights into the genesis of epilepsy

  1999cited by this paper
• Diamondoids and oil are not forever

  1999cited by this paper
• Lamotrigine and Seizure Aggravation in Severe Myoclonic Epilepsy

  1998cited by this paper
• GLUT-1 deficiency syndrome caused by haploinsufficiency of the blood-brain barrier hexose carrier

  1998cited by this paper
• A potassium channel mutation in neonatal human epilepsy.

  1998cited by this paper
• Generalized epilepsy with febrile seizures plus. A genetic disorder with heterogeneous clinical phenotypes.

  1997cited by this paper
• Defective glucose transport across the blood-brain barrier as a cause of persistent hypoglycorrhachia, seizures, and developmental delay.

  1991cited by this paper

• Dynamic Susceptibility Contrast Enhanced (DSC) MRI Perfusion and Plasma Cytokine Levels in Patients after Tonic-clonic Seizures

  2017cites this paper